-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Turnstone Biologics Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2022 to Q4 2024.
- Turnstone Biologics Corp. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $704K, a 35.2% decline year-over-year.
- Turnstone Biologics Corp. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $3.68M, a 12.8% decline year-over-year.
- Turnstone Biologics Corp. annual Share-based Payment Arrangement, Expense for 2024 was $3.68M, a 12.8% decline from 2023.
- Turnstone Biologics Corp. annual Share-based Payment Arrangement, Expense for 2023 was $4.22M, a 3.48% decline from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)